scispace - formally typeset
M

Margaret Wallen

Researcher at Australian Catholic University

Publications -  107
Citations -  2070

Margaret Wallen is an academic researcher from Australian Catholic University. The author has contributed to research in topics: Cerebral palsy & Occupational therapy. The author has an hindex of 24, co-authored 93 publications receiving 1838 citations. Previous affiliations of Margaret Wallen include Caps & The Advisory Board Company.

Papers
More filters
Journal ArticleDOI

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE)

TL;DR: A combination of BoNT-A and occupational therapy is more effective than occupational therapy alone in reducing impairment, improving activity level outcomes and goal achievement, but not for improving quality of life or perceived self-competence.
Journal ArticleDOI

Functional Outcomes of Intramuscular Botulinum Toxin Type A and Occupational Therapy in the Upper Limbs of Children With Cerebral Palsy: A Randomized Controlled Trial

TL;DR: OT enhanced individualized functional outcomes following BTX-A injections in the upper limbs of children with CP resulted in accelerated attainment of functional goals measured by the COPM and GAS.
Journal ArticleDOI

Modified constraint-induced therapy for children with hemiplegic cerebral palsy: a randomized trial

TL;DR: The aim of this study was to determine the effects of modified constraint‐induced therapy compared with intensive occupational therapy on activities of daily living and upper limb outcomes in children with hemiplegic CP.
Journal ArticleDOI

Evidence‐based practice for occupational therapists

TL;DR: According to systematic reviews from AOTA’s EvidenceBased Practice Occupational Therapy Practice Guidelines, evidence shows that the following occupational therapy interventions improve client outcomes.
Journal ArticleDOI

Functional outcomes of intramuscular botulinum toxin type A in the upper limbs of children with cerebral palsy: a phase II trial.

TL;DR: Sustained functional outcomes occurred after botulinum toxin injections despite increasing muscle tone after an initial reduction in tone, and Randomized controlled trials are required.